ADAM10 and early-onset autosomal dominant Alzheimer disease: In this publication, the authors screened an FDA-approved drug libraryand identified 1 as a novel ADAM10 gene expression enhancer.In fact, 1 increased ADAM10 production in human neuronalcells in vitro and in peripheral blood cells in amouse model of Alzheimer’s disease.